title: [Probability of control of the patient with diabetes exclusively treated with pharmacological therapy].
abstract: OBJECTIVE
  to predict the probability of blood glucose control in patients with type-2 diabetes mellitus, exclusively treated with pharmacology therapy.
  
  
  METHODS
  secondary analysis of a database to evaluate the therapeutic attachment in type-2 diabetics older than 60 years old. We interviewed 123 patients in their home to get information about sociodemographic aspects and diabetes characteristics. The blood glucose control was measured through glycated hemoglobin and the attachment to the pharmacological treatment was measured by the Morisky-Green test. The analysis included simple logistic regression; the calculation of probability of control for different levels of therapeutic attachment was estimated using the result of the regression equation (y) and applying the formula 1/1 + e(-y).
  
  
  RESULTS
  Monotherapy was present in 82.1%, glibenclamide was prescribed alone in 77.2%, glycated hemoglobin average was 11.5 +/- 3.5 %, 18% of the population was controlled and 58.1% showed some attachment to the pharmacological treatment. With a total attachment to the pharmacological prescription, the control probability is 27%, and without it, it corresponds to 10%.
  
  
  CONCLUSIONS
  Almost three out of ten patients with a total attachment to the pharmacological treatment have chances of being controlled.
authors.affiliation: Unidad de Investigación Epidemiológica y en Servicios de Salud, Querétaro, Insituto Mexicano del Seguro Social. felibree@infosel.net.mx
authors.forename: Enrique
authors.initials: E
authors.lastname: Villarreal-Ríos
authors.forename: Alejandro
authors.initials: A
authors.lastname: Paredes-Chaparro
authors.forename: Lidia
authors.initials: L
authors.lastname: Martínez-González
authors.forename: Liliana
authors.initials: L
authors.lastname: Galicia-Rodríguez
authors.forename: Emma
authors.initials: E
authors.lastname: Vargas-Daza
authors.forename: María Eugenia
authors.initials: ME
authors.lastname: Garza-Elizondo
mesh_terms: D020909:Acarbose / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D008875:Middle Aged; D011336:Probability; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin; D005905:Glyburide; D020909:Acarbose